Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5174081
Max Phase: Preclinical
Molecular Formula: C54H74N12O14S
Molecular Weight: 1147.32
Associated Items:
ID: ALA5174081
Max Phase: Preclinical
Molecular Formula: C54H74N12O14S
Molecular Weight: 1147.32
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C54H74N12O14S/c1-5-29(4)45-53(80)60-36(7-6-20-58-54(56)57)47(74)61-37(21-28(2)3)48(75)62-39(23-31-10-16-34(68)17-11-31)49(76)64-41(25-44(71)72)51(78)63-40(24-32-12-18-35(69)19-13-32)50(77)65-42(46(55)73)26-81-27-43(70)59-38(52(79)66-45)22-30-8-14-33(67)15-9-30/h8-19,28-29,36-42,45,67-69H,5-7,20-27H2,1-4H3,(H2,55,73)(H,59,70)(H,60,80)(H,61,74)(H,62,75)(H,63,78)(H,64,76)(H,65,77)(H,66,79)(H,71,72)(H4,56,57,58)/t29-,36-,37-,38-,39-,40-,41-,42-,45-/m0/s1
Standard InChI Key: XASJTHJCJUPOBO-DKFLDVSASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1147.32 | Molecular Weight (Monoisotopic): 1146.5168 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Fleming MC, Chiou LF, Tumbale PP, Droby GN, Lim J, Norris-Drouin JL, Williams JG, Pearce KH, Williams RS, Vaziri C, Bowers AA.. (2022) Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4., 65 (10.0): [PMID:35522528] [10.1021/acs.jmedchem.2c00185] |
Source(1):